<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04509128</url>
  </required_header>
  <id_info>
    <org_study_id>RP 19/19</org_study_id>
    <nct_id>NCT04509128</nct_id>
  </id_info>
  <brief_title>Ultrasonographic Evaluation of Diaphragm and Quadriceps in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
  <acronym>EDIFEB</acronym>
  <official_title>Echographic Characteristics of DIaphragm and FEmoral Quadriceps in COPD Patients: Evaluation of Their Relationship With the Lung Function Impairment and the Effect of Pulmonary Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the prognostic role of echographic diaphragmatic&#xD;
      assessment and vastus lateralis muscle ultrasound (US) in two independent populations of&#xD;
      patients hospitalized for exacerbated Chronic Obstructive Pulmonary Disease (COPD) or&#xD;
      undergoing pulmonary rehabilitation.&#xD;
&#xD;
      Specific aims of this protocol are: 1) to analyze the correlation between qualitative and&#xD;
      quantitative US parameters and severity of illness indicators and respiratory function data;&#xD;
      2) to detect the postrehabilitation outcomes in terms of diaphragmatic and vastus lateralis&#xD;
      muscle function, assessed by US, and the correlation between these outcomes and indicators of&#xD;
      pulmonary rehabilitation treatment effectiveness; 3) to evaluate the ability of qualitative&#xD;
      and quantitative US parameters to predict in-hospital mortality and length of stay; 4) to&#xD;
      evaluate the ability of qualitative and quantitative US parameters to predict exacerbation&#xD;
      rate, hospitalization rate and mortality rate six months after the discharge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship between diaphragmatic and vastus lateralis muscle function and severity of illness indicators and respiratory function data</measure>
    <time_frame>At discharge from hospital, estimated average of 10 days for Group A patients, and 28 days for Group B patients</time_frame>
    <description>Evaluation of the correlation between qualitative and quantitative diaphragmatic and vastus lateralis muscle ultrasound parameters and the degree of respiratory function impairment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variations of diaphragmatic and vastus lateralis muscle function, assessed by US, after 4 weeks of in-hospital Pulmonary Rehabilitation</measure>
    <time_frame>After 4 weeks of Pulmonary Rehabilitation (T1)</time_frame>
    <description>Evaluation of the post rehabilitation outcomes in terms of diaphragmatic and vastus lateralis muscle function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relationship between post rehabilitation changes in diaphragmatic and vastus lateralis muscle function and indicators of pulmonary rehabilitation treatment effectiveness</measure>
    <time_frame>After 4 weeks of Pulmonary Rehabilitation (T1)</time_frame>
    <description>Evaluation of the correlation between post rehabilitation qualitative and quantitative diaphragmatic and vastus lateralis muscle ultrasound parameters and indicators of pulmonary rehabilitation treatment effectiveness (mMRC, Modified Medical Research Council, Dyspnea Scale; distance in meters at six minute walking test; respiratory function data; arterial blood gas values)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prediction of in-hospital mortality by means of parameters of diaphragmatic and vastus lateralis muscle function</measure>
    <time_frame>At discharge from hospital, estimated average of 10 days for Group A patients, and 28 days for Group B patients</time_frame>
    <description>Evaluation of the ability of qualitative and quantitative diaphragmatic and vastus lateralis muscle ultrasound parameters to predict in-hospital mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of length of stay by means of parameters of diaphragmatic and vastus lateralis muscle function</measure>
    <time_frame>At discharge from hospital, estimated average of 10 days for Group A patients, and 28 days for Group B patients</time_frame>
    <description>Evaluation of the ability of qualitative and quantitative diaphragmatic and vastus lateralis muscle ultrasound parameters to predict length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of COPD exacerbation rate by means of parameters of diaphragmatic and vastus lateralis muscle function</measure>
    <time_frame>Six months after discharge (T2)</time_frame>
    <description>Evaluation the ability of qualitative and quantitative US parameters to predict COPD exacerbation rate six months after the discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of hospitalization rate by means of parameters of diaphragmatic and vastus lateralis muscle function</measure>
    <time_frame>Six months after discharge (T2)</time_frame>
    <description>Evaluation the ability of qualitative and quantitative US parameters to predict hospitalization rate six months after the discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of mortality rate by means of parameters of diaphragmatic and vastus lateralis muscle function</measure>
    <time_frame>Six months after discharge (T2)</time_frame>
    <description>Evaluation the ability of qualitative and quantitative US parameters to predict mortality rate six months after the discharge</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>COPD</condition>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Subjects hospitalized for a COPD acute exacerbation, undergoing arterial blood gas analysis, evaluation of presence and grade of dyspnea, handgrip strength test, and diaphragmatic and vastus lateralis muscle ultrasound assessment, at admission and discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <description>Subjects referred for pulmonary rehabilitation (PR) after a hospitalized COPD exacerbation, undergoing pulmonary function test, arterial blood gas analysis, evaluation of presence and grade of dyspnea, handgrip strength test, and diaphragmatic and vastus lateralis muscle ultrasound assessment, before and after PR.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Group A: Subjects hospitalizated for a COPD acute exacerbation Group B: Subjects referred&#xD;
        for pulmonary rehabilitation (PR) after a hospitalized COPD exacerbation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (Group A):&#xD;
&#xD;
          -  COPD diagnosis&#xD;
&#xD;
          -  previous or actual cigarette smoking history&#xD;
&#xD;
          -  COPD exacerbation requiring hospitalization&#xD;
&#xD;
          -  Obtained written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pleural effusion extended for more than two intercostal spaces&#xD;
&#xD;
          -  Interstitial lung diseases&#xD;
&#xD;
          -  Major surgery in the previous 30 days&#xD;
&#xD;
          -  Right pleurodesis or fibrothorax&#xD;
&#xD;
          -  Right stroke outcomes&#xD;
&#xD;
          -  Technical impossibility to perform ultrasound evaluations&#xD;
&#xD;
          -  conditions, clinical or otherwise, that in the investigator's judgment may interfere&#xD;
             with the study, or not recommending participation for security reasons&#xD;
&#xD;
          -  Absence of written informed consent&#xD;
&#xD;
        Inclusion Criteria (Group B):&#xD;
&#xD;
          -  COPD diagnosis&#xD;
&#xD;
          -  previous or actual cigarette smoking history&#xD;
&#xD;
          -  COPD exacerbation requiring hospitalization in the previous 30 days&#xD;
&#xD;
          -  Indication to undergo a pulmonary rehabilitation protocol&#xD;
&#xD;
          -  Obtained written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pleural effusion extended for more than two intercostal spaces&#xD;
&#xD;
          -  Interstitial lung diseases&#xD;
&#xD;
          -  Major surgery in the previous 30 days&#xD;
&#xD;
          -  Right pleurodesis or fibrothorax&#xD;
&#xD;
          -  Right stroke outcomes&#xD;
&#xD;
          -  Technical impossibility to perform ultrasound evaluations&#xD;
&#xD;
          -  conditions, clinical or otherwise, that in the investigator's judgment may interfere&#xD;
             with the study, or not recommending participation for security reasons&#xD;
&#xD;
          -  Absence of written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vittoria Conti, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unit of Pulmonay Rehabilitation, IRCCS San Raffaele Pisana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vittoria Conti, PhD</last_name>
    <phone>0039 338 2163293</phone>
    <email>vittoria.conti@sanraffaele.it</email>
  </overall_contact>
  <link>
    <url>https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf</url>
    <description>GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines</description>
  </link>
  <reference>
    <citation>Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med. 2005 Dec;99 Suppl B:S3-10. Epub 2005 Oct 10. Review.</citation>
    <PMID>16219454</PMID>
  </reference>
  <reference>
    <citation>Koerts-de Lang E, Schols AM, Rooyackers OE, Gayan-Ramirez G, Decramer M, Wouters EF. Different effects of corticosteroid-induced muscle wasting compared with undernutrition on rat diaphragm energy metabolism. Eur J Appl Physiol. 2000 Aug;82(5-6):493-8.</citation>
    <PMID>10985606</PMID>
  </reference>
  <reference>
    <citation>Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994 Jul;150(1):11-6.</citation>
    <PMID>8025735</PMID>
  </reference>
  <reference>
    <citation>Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo). 2010 Jun;65(6):599-605. doi: 10.1590/S1807-59322010000600007.</citation>
    <PMID>20613936</PMID>
  </reference>
  <reference>
    <citation>Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002 Sep 15;166(6):809-13.</citation>
    <PMID>12231489</PMID>
  </reference>
  <reference>
    <citation>Montes de Oca M, Torres SH, Gonzalez Y, Romero E, Hernández N, Mata A, Tálamo C. Peripheral muscle composition and health status in patients with COPD. Respir Med. 2006 Oct;100(10):1800-6. Epub 2006 Mar 20.</citation>
    <PMID>16545558</PMID>
  </reference>
  <reference>
    <citation>Thurlbeck WM. Diaphragm and body weight in emphysema. Thorax. 1978 Aug;33(4):483-7.</citation>
    <PMID>694801</PMID>
  </reference>
  <reference>
    <citation>Arora NS, Rochester DF. Effect of body weight and muscularity on human diaphragm muscle mass, thickness, and area. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):64-70.</citation>
    <PMID>7061279</PMID>
  </reference>
  <reference>
    <citation>Rochester DF. The diaphragm: contractile properties and fatigue. J Clin Invest. 1985 May;75(5):1397-402. Review.</citation>
    <PMID>3889054</PMID>
  </reference>
  <reference>
    <citation>Cesari M, Pedone C, Chiurco D, Cortese L, Conte ME, Scarlata S, Incalzi RA. Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease. Age Ageing. 2012 Mar;41(2):237-41. doi: 10.1093/ageing/afr167. Epub 2011 Dec 8.</citation>
    <PMID>22156558</PMID>
  </reference>
  <reference>
    <citation>Ticinesi A, Meschi T, Narici MV, Lauretani F, Maggio M. Muscle Ultrasound and Sarcopenia in Older Individuals: A Clinical Perspective. J Am Med Dir Assoc. 2017 Apr 1;18(4):290-300. doi: 10.1016/j.jamda.2016.11.013. Epub 2017 Feb 13. Review.</citation>
    <PMID>28202349</PMID>
  </reference>
  <reference>
    <citation>Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.</citation>
    <PMID>20392703</PMID>
  </reference>
  <reference>
    <citation>McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, Kenny AM, Peters KW, Ferrucci L, Guralnik JM, Kritchevsky SB, Kiel DP, Vassileva MT, Xue QL, Perera S, Studenski SA, Dam TT. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):576-83. doi: 10.1093/gerona/glu012.</citation>
    <PMID>24737560</PMID>
  </reference>
  <reference>
    <citation>Cesari M, Landi F, Calvani R, Cherubini A, Di Bari M, Kortebein P, Del Signore S, Le Lain R, Vellas B, Pahor M, Roubenoff R, Bernabei R, Marzetti E; SPRINTT Consortium. Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial. Aging Clin Exp Res. 2017 Feb;29(1):81-88. doi: 10.1007/s40520-016-0716-1. Epub 2017 Feb 10.</citation>
    <PMID>28188558</PMID>
  </reference>
  <reference>
    <citation>Ticinesi A, Narici MV, Lauretani F, Nouvenne A, Colizzi E, Mantovani M, Corsonello A, Landi F, Meschi T, Maggio M. Assessing sarcopenia with vastus lateralis muscle ultrasound: an operative protocol. Aging Clin Exp Res. 2018 Dec;30(12):1437-1443. doi: 10.1007/s40520-018-0958-1. Epub 2018 Apr 26.</citation>
    <PMID>29700758</PMID>
  </reference>
  <reference>
    <citation>Iwasawa T, Takahashi H, Ogura T, Asakura A, Gotoh T, Shibata H, Inoue T. Influence of the distribution of emphysema on diaphragmatic motion in patients with chronic obstructive pulmonary disease. Jpn J Radiol. 2011 May;29(4):256-64. doi: 10.1007/s11604-010-0552-8. Epub 2011 May 24.</citation>
    <PMID>21607839</PMID>
  </reference>
  <reference>
    <citation>Podnar S, Harlander M. Phrenic nerve conduction studies in patients with chronic obstructive pulmonary disease. Muscle Nerve. 2013 Apr;47(4):504-9. doi: 10.1002/mus.23617. Epub 2013 Feb 4.</citation>
    <PMID>23382059</PMID>
  </reference>
  <reference>
    <citation>Zanforlin A, Giannuzzi R, Nardini S, Testa A, Soldati G, Copetti R, Marchetti G, Valente S, Inchingolo R, Smargiassi A. The role of chest ultrasonography in the management of respiratory diseases: document I. Multidiscip Respir Med. 2013 Aug 9;8(1):54. doi: 10.1186/2049-6958-8-54.</citation>
    <PMID>23937880</PMID>
  </reference>
  <reference>
    <citation>Rodrigues FM, Demeyer H, Loeckx M, Hornikx M, Van Remoortel H, Janssens W, Troosters T. Health status deterioration in subjects with mild to moderate airflow obstruction, a six years observational study. Respir Res. 2019 May 18;20(1):93. doi: 10.1186/s12931-019-1061-7.</citation>
    <PMID>31103027</PMID>
  </reference>
  <reference>
    <citation>Martinez CH, Diaz AA, Meldrum CA, McDonald MN, Murray S, Kinney GL, Hokanson JE, Curtis JL, Bowler RP, Han MK, Washko GR, Regan EA; COPDGene Investigators. Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition. Ann Am Thorac Soc. 2017 Nov;14(11):1638-1645. doi: 10.1513/AnnalsATS.201610-821OC.</citation>
    <PMID>29090990</PMID>
  </reference>
  <reference>
    <citation>Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.</citation>
    <PMID>24127811</PMID>
  </reference>
  <reference>
    <citation>Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, Crimi N. Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018 Oct 8;13:3131-3139. doi: 10.2147/COPD.S171134. eCollection 2018.</citation>
    <PMID>30349221</PMID>
  </reference>
  <reference>
    <citation>Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker PP, Walmsley S; British Thoracic Society Pulmonary Rehabilitation Guideline Development Group; British Thoracic Society Standards of Care Committee. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013 Sep;68 Suppl 2:ii1-30. doi: 10.1136/thoraxjnl-2013-203808.</citation>
    <PMID>23880483</PMID>
  </reference>
  <reference>
    <citation>Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013 Apr;10(2):81-9. doi: 10.1513/AnnalsATS.201208-043OC. Review.</citation>
    <PMID>23607835</PMID>
  </reference>
  <reference>
    <citation>Scarlata S, Mancini D, Laudisio A, Benigni A, Antonelli Incalzi R. Reproducibility and Clinical Correlates of Supine Diaphragmatic Motion Measured by M-Mode Ultrasonography in Healthy Volunteers. Respiration. 2018;96(3):259-266. doi: 10.1159/000489229. Epub 2018 Aug 16.</citation>
    <PMID>30114702</PMID>
  </reference>
  <reference>
    <citation>Scarlata S, Mancini D, Laudisio A, Raffaele AI. Reproducibility of diaphragmatic thickness measured by M-mode ultrasonography in healthy volunteers. Respir Physiol Neurobiol. 2019 Feb;260:58-62. doi: 10.1016/j.resp.2018.12.004. Epub 2018 Dec 13.</citation>
    <PMID>30553945</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 3, 2020</study_first_submitted>
  <study_first_submitted_qc>August 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2020</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Vittoria Conti</investigator_full_name>
    <investigator_title>First Level Medical Manager, Department of Respiratory Disease</investigator_title>
  </responsible_party>
  <keyword>Multidimensional evaluation</keyword>
  <keyword>COPD</keyword>
  <keyword>Pulmonary rehabilitation</keyword>
  <keyword>Diaphragmatic ultrasound</keyword>
  <keyword>Vastus lateralis muscle ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

